Search
LV-SMENP Vaccine
go.drugbank.com/drugs/DB15804ExperimentalLV-SMENP-DC is a vaccine candidate being developed by Shenzhen Geno-Immune Medical Institute that comprises dendritic cells that are modified with lentiviral vector-expressing synthetic minigene which
Plosaracetam
go.drugbank.com/drugs/DB21594InvestigationalPlosaracetam has a monoisotopic molecular weight of 330.05 Da.
Icalcaprant
go.drugbank.com/drugs/DB21651InvestigationalIcalcaprant has a monoisotopic molecular weight of 406.2 Da.
Olomorasib
go.drugbank.com/drugs/DB21697InvestigationalOlomorasib has a monoisotopic molecular weight of 528.08 Da.
Istisociclib
go.drugbank.com/drugs/DB21703InvestigationalIstisociclib has a monoisotopic molecular weight of 287.21 Da.
Efonidipine
go.drugbank.com/drugs/DB09235InvestigationalEfonidipine is a calcium channel blocker of the dihydropyridine class, commercialized by Shionogi & Co. (Japan). Initially, it was marketed in 1995 under the trade name, Landel. The drug has been shown to block T-type in addition to ...
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A InhibitorsCoVac-1
go.drugbank.com/drugs/DB16429InvestigationalSponsored by the University Hospital Tuebingen in Germany, CoVac-1 is a multi-peptide COVID-19 vaccine candidate created from HLA class I and HLA-DR T-cell epitopes of the S-protein[A226588].
MBO7133
go.drugbank.com/drugs/DB04999ExperimentalHigher doses of araC cannot be used to overcome this limitation due to bone marrow toxicity resulting from rapid activation in that tissue. … However, araC is only slowly converted to araCTP in the liver or in primary liver tumors due to low levels of an enzyme in the liver that is required for the conversion of araC to araCMP, the first step
Casdatifan
go.drugbank.com/drugs/DB21701InvestigationalCasdatifan has a monoisotopic molecular weight of 439.09 Da.
Amredobresib
go.drugbank.com/drugs/DB21566InvestigationalAmredobresib has a monoisotopic molecular weight of 467.25 Da.